Stockreport

ProMIS Neurosciences to Participate in the 37th Annual Roth Conference

ProMIS Neurosciences Inc. - Common Shares  (PMN) 
PDF CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation [Read more]